Intravenous Immunoglobulin Market: Rise in Prevalence of Autoimmune Disorders to Drive the Market
The global intravenous immunoglobulin (IVIG) market is prognosticated to witness solid growth in the coming years, according to report published by Transparency Market Research (TMR). The market's vendor landscape features high amount of consolidation. The leading four players, Grifols S.A., CSL Behring LLC, Baxalta Incorporated, and Octapharma AG, held over two-thirds of the overall market share in 2017, with Grifols S.A. holding maximum traction in the market. The dominance of this company could be attributed to the strong geographical presence...
View full press release